Literature DB >> 23748591

3rd Brazilian Consensus on Helicobacter pylori.

Luiz Gonzaga Coelho1, Ismael Maguinilk, Schlioma Zaterka, José Miguel Parente, Maria do Carmo Friche Passos, Joaquim Prado P Moraes-Filho.   

Abstract

Signicant progress has been obtained since the Second Brazilian Consensus Conference on Helicobacter pylori Infection held in 2004, in São Paulo, SP, Brazil, and justify a third meeting to establish updated guidelines on the current management of H. pylori infection. The Third Brazilian Consensus Conference on H pylori Infection was organized by the Brazilian Nucleus for the Study of Helicobacter, a Department of the Brazilian Federation of Gastroenterology and took place on April 12-15, 2011, in Bento Gonçalves, RS, Brazil. Thirty-one delegates coming from the five Brazilian regions and one international guest, including gastroenterologists, pathologists, epidemiologists, and pediatricians undertook the meeting. The participants were allocated in one of the five main topics of the meeting: H pylori, functional dyspepsia and diagnosis; H pylori and gastric cancer; H pylori and other associated disorders; H pylori treatment and retreatment; and, epidemiology of H pylori infection in Brazil. The results of each subgroup were submitted to a final consensus voting to all participants. Relevant data were presented, and the quality of evidence, strength of recommendation, and level of consensus were graded. Seventy per cent and more votes were considered as acceptance for the final statement. This article presents the main recommendations and conclusions to guide Brazilian doctors involved in the management of H pylori infection.

Entities:  

Mesh:

Year:  2013        PMID: 23748591     DOI: 10.1590/S0004-28032013005000001

Source DB:  PubMed          Journal:  Arq Gastroenterol        ISSN: 0004-2803


  13 in total

Review 1.  Second and third line treatment options for Helicobacter pylori eradication.

Authors:  Mingjun Song; Tiing Leong Ang
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 2.  Hematologic manifestations of Helicobacter pylori infection.

Authors:  Germán Campuzano-Maya
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

Review 3.  Pharmacological therapy used in the elimination of Helicobacter pylori infection: a review.

Authors:  Ariolana A Dos Santos; Adriana A Carvalho
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

4.  Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial.

Authors:  Ayse Kefeli; Sebahat Basyigit; Abdullah Ozgur Yeniova; Tarık Tayfur Kefeli; Muzaffer Aslan; Ozlem Tanas
Journal:  Bosn J Basic Med Sci       Date:  2016-01-01       Impact factor: 3.363

5.  Comparison of Second-Line Quadruple Therapies with or without Bismuth for Helicobacter pylori Infection.

Authors:  Guang-Hong Jheng; I-Chen Wu; Hsiang-Yao Shih; Meng-Chieh Wu; Fu-Chen Kuo; Huang-Ming Hu; Chung-Jung Liu; Wen-Hung Hsu; Chi-Tan Hu; Ming-Jong Bair; Chao-Hung Kuo; Deng-Chyang Wu; Ping-I Hsu
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

6.  Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial.

Authors:  Jaime Natan Eisig; Tomás Navarro-Rodriguez; Ana Cristina Sá Teixeira; Fernando Marcuz Silva; Rejane Mattar; Decio Chinzon; Christiane Haro; Márcio Augusto Diniz; Joaquim Prado Moraes-Filho; Ronnie Fass; Ricardo Correa Barbuti
Journal:  Gastroenterol Res Pract       Date:  2015-05-04       Impact factor: 2.260

7.  Efficacy of levofloxacin, amoxicillin and a proton pump inhibitor in the eradication of Helicobacter pylori in Brazilian patients with peptic ulcers.

Authors:  Fernando Marcuz Silva; Elaine Cristina Silveira de Queiroz; Tomás Navarro-Rodriguez; Ricardo Correa Barbuti; Rejane Mattar; Kiyoshi Iriya; Jin Hwa Lee; Jaime Natan Eisig
Journal:  Clinics (Sao Paulo)       Date:  2015-05-01       Impact factor: 2.365

8.  Efficacy of Clarithromycin Containing Bismuth-Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication.

Authors:  Marjan Mokhtare; Shahram Agah; Hafez Fakheri; Vahid Hosseini; Mohsen Rezaei Hemami; Seyed Mohammad Sadegh Ghafoori
Journal:  Middle East J Dig Dis       Date:  2015-04

9.  GASTRIC STUMP CANCER AFTER GASTRECTOMY BY GASTRODUODENAL PEPTIC ULCER.

Authors:  Augusto Diogo Filho; Lucas Ferreira Botelho; Andréa Nishiyama; Letícia Eugênia Zumpano; Rosana Caldeira Monte; Samantha Cunha Rosa
Journal:  Arq Bras Cir Dig       Date:  2016-03

10.  Detection of Helicobacter pylori resistance to clarithromycin and fluoroquinolones in Brazil: A national survey.

Authors:  Bruno Squarcio Sanches; Gustavo Miranda Martins; Karine Lima; Bianca Cota; Luciana Dias Moretzsohn; Laercio Tenorio Ribeiro; Helenice P Breyer; Ismael Maguilnik; Aline Bessa Maia; Joffre Rezende-Filho; Ana Carolina Meira; Henrique Pinto; Edson Alves; Ramiro Mascarenhas; Raissa Passos; Julia Duarte de Souza; Osmar Reni Trindade; Luiz Gonzaga Coelho
Journal:  World J Gastroenterol       Date:  2016-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.